A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude… read more.
Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the… read more.
Researchers at UNSW Sydney and Neuroscience Research Australia (NeuRA) have developed and evaluated a tool for assessing dementia risk, with promising initial results. Currently, over 55 million people are living with dementia… read more.
Researchers at the University of Calgary in Canada and the University of Exeter in the United Kingdom explored the relationship between vitamin D supplementation and dementia in more… read more.
New research at the University of Chicago Medicine has found that a drug commonly used to treat symptoms of Alzheimer’s disease effectively reduced symptoms of adults who experience… read more.
Social lifestyle determinants, including social isolation, are associated with neurodegeneration risk factors, according to a new study published PLOS ONE by scientists at McGill University, Canada. Alzheimer’s disease (AD) is… read more.
An international team of researchers including Sofya Kulikova, Senior Research Fellow at the HSE University-Perm, found that ketamine, being an NMDA receptor inhibitor, increases the brain’s background noise, causing higher… read more.
Compared to other experimental therapies, treatment with the ADHD medication lisdexamfetamine resulted in the lowest risk of hospitalization and death among people with amphetamine addiction, researchers reported on… read more.
Despite the continuing growth of benzodiazepine (BZD)-related overdoses, BZD prescription rates have held constant. Much is unknown about how a doctor’s own beliefs about BZD use and potential… read more.
Demand for mental health treatment has continued to increase as many psychologists report no longer having the capacity to see new patients, according to a new survey by… read more.
A research team from the Centre for Safe Medication Practice and Research (CSMPR), Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (HKUMed)… read more.
Older people who were infected with COVID-19 show a substantially higher risk—as much as 50% to 80% higher than a control group—of developing Alzheimer’s disease within a year,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
